PRF Technologies Ltd. (PRFX) News
Track canonical SquawkNews coverage tagged to PRFX, PRF Technologies Ltd.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 10 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
S.H.N. Financial Investments Seeks Board Shake-Up at PRF Technologies with 5.716% Stake
S.H.N. Financial Investments Ltd. disclosed a 5.716% stake in PRF Technologies Ltd. through a Schedule 13D. On Sep. 24, 2026, the firm also sent a letter calling for a special meeting of shareholders. The move signals an
NEWS | Sep 24, 2026, 08:39 PM UTC
L
PRFX - PRF Technologies’ GridFeed(TM) to Explore Strategic Growth Opportunity in AI Data Center Power Optimization
PRFX - PRF Technologies’ GridFeed(TM) to Explore Strategic Growth Opportunity in AI Data Center Power Optimization
NEWS | Sep 16, 2026, 01:01 PM UTC
L
PRF Technologies to establish GridFeed as standalone subsidiary
PRFX will establish GridFeed as a standalone subsidiary to pursue strategic alliances for its AI-driven renewable energy trading platform.
EQUITY | Sep 09, 2026, 12:30 PM UTC
M
PRF Technologies FDA clears IND for OcuRing-K Phase II trial
PRF Technologies said the FDA cleared the IND for OcuRing™-K, enabling a U.S. multi-center Phase II trial in cataract surgery. Patient enrollment is expected in the second half of 2026.
REGULATION | Sep 03, 2026, 12:37 PM UTC
L
PRF Technologies 1H Loss $2.8M >PRFX
PRF Technologies 1H Loss $2.8M >PRFX
EQUITY | Sep 03, 2026, 12:33 PM UTC
L
PRFX provides first-half 2026 business update
PRF Technologies issued a first-half 2026 business update.
EQUITY | Sep 03, 2026, 12:32 PM UTC
L
PRFX - PRF Technologies Issues Letter to Shareholders Highlighting Strengthened Financial Position and Building Momentum Across Its Biotechn
PRFX - PRF Technologies Issues Letter to Shareholders Highlighting Strengthened Financial Position and Building Momentum Across Its Biotechnology and AI -Driven Energy Platforms
EQUITY | Jul 27, 2026, 12:30 PM UTC
M
PRFX Reports Preclinical Results
PRF Technologies reports expanded preclinical results for PRF-110, showing comparable analgesic efficacy to ZYNRELEF
EQUITY | Jun 25, 2026, 12:30 PM UTC
L
CDNL: Proposes Public Offering
CDNL proposes public offering of common stock
EQUITY | Jun 23, 2026, 09:24 AM UTC
M
CDNL: Proposes Public Offering
CDNL proposes public offering of common stock, among other equity offerings from various companies
EQUITY | Jun 22, 2026, 09:10 PM UTC